Skip to main content

Find Clinical Trials

Home
Conditions
Uterine Cervical Neoplasms

Clinical trial condition

Uterine Cervical Neoplasms

Explore clinical trials studying Uterine Cervical Neoplasms. Study availability and eligibility vary by location and protocol.

1,616 public trials 364 recruiting studies

Refine in advanced search Browse all conditions

Uterine Cervical Neoplasms trial results

Completed

UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia

NCT00003598

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

NCT00423254

Conditions: Adenocarcinoma, Adenoma, Anal Carcinoma, +97 more
Locations: Arizona Cancer Center Tuscon, Arizona, United States

Lombardi Comprehensive Cancer Center at Georgetown Washington D.C., District of Columbia, United States

H Lee Moffitt Cancer Center University of So Florida Tampa, Florida, United States

Nevada Cancer Institute Sparks, Nevada, United States

View Trial Details

Completed

Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours

NCT00189410

Conditions: Cancer of the Ovary Treated as 2nd Line Therapy, Cervical Cancers, Female Urogenital Diseases, +15 more
Locations: Medical Practice Dr. Klare Berlin, Germany

Evangelisches Krankenhaus, Dept. of Gynecology & Obstetrics Düsseldorf, Germany

Univerisity Hospital; Dept. of Gynecology & Obstetrics Erlangen, Germany

University hospital, Dept. of gynecology & obstetrics Essen, Germany

View all 19 locations

View Trial Details

Completed

Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer

NCT00005941

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Investigation of the Uterine Cervix Using CervicalMD

NCT00839475

Conditions: Colposcopy, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Not specified

View Trial Details

Completed

Spectroscopy in Diagnosing Dysplasia and Neoplasia in the Cervix in Women Undergoing Colposcopy

NCT00632190

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +14 more
Locations: Not specified

View Trial Details

Completed

Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer

NCT00320983

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: University of New Mexico Albuquerque, New Mexico, United States

View Trial Details

Completed

DNA Cytometry for Cervical Cancer Screening in China

NCT00902551

Conditions: Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Nanjing Maternal and Child Health Care Hospital Nanjing, Jiangsu, China

View Trial Details

Completed

Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma

NCT00165126

Conditions: Carcinoma of the Uterus, Cervix Cancer, Endometrial Carcinoma, +14 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Dosimetric Planning Study Comparing Intensity Modulated Radiotherapy (IMRT) and 4-field Radiotherapy for Definitive Treatment of Cancer of the Cervix

NCT00981552

Conditions: Cervix Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Sunnybrook Health Sciences Centre Toronto, Ontario, Canada

View Trial Details